(DailyAnswer.org) – A progressive congresswoman who champions marijuana reform secretly tried to build her own cannabis empire while simultaneously defending an accused killer in a deadly drug deal.
Story Highlights
- Rep. Jasmine Crockett attempted to secure marijuana dispensary licenses in Ohio through her firm Black Diamond Investments while serving as a 20% owner
- She defended a client convicted of murder in a marijuana deal gone bad during the same period she pursued cannabis business ventures
- Crockett failed to disclose significant stock holdings in cannabis and other industries during her congressional campaign
- Ethics watchdogs are calling for investigations into her undisclosed financial interests and potential conflicts of interest
The Double Life of a Cannabis Crusader
Rep. Jasmine Crockett’s public persona as a civil rights attorney fighting for marijuana justice masks a more complex reality. Between 2018 and 2020, the Texas Democrat served as chief operations officer and 20% owner of Black Diamond Investments, a firm aggressively pursuing medical marijuana dispensary licenses in Ohio. This business venture remained hidden from voters during her 2022 congressional campaign, where she positioned herself as a champion of the underserved.
The timing reveals a troubling pattern. While Black Diamond Investments sought to profit from Ohio’s medical marijuana program, Crockett simultaneously defended Tyvon Montrel Gullatt, who faced murder charges in a marijuana deal that turned deadly. Gullatt was ultimately convicted and sentenced to life in prison. This dual role raises serious questions about her motivations and ethical boundaries.
Hidden Wealth and Disclosure Failures
Crockett’s financial disclosures paint a picture of selective transparency. She reported stock holdings to Texas state authorities in 2021 but conveniently omitted these same investments from federal disclosure requirements when running for Congress. Her portfolio included stakes in pharmaceutical companies, fossil fuel enterprises, and cannabis businesses – industries directly affected by her legislative positions.
Americans for Public Trust, a government ethics watchdog, discovered these discrepancies through investigative analysis. The organization found that Crockett’s public image as a grassroots advocate conflicts sharply with her undisclosed business interests. Her failure to report these holdings violates the spirit, if not the letter, of congressional ethics rules designed to prevent conflicts of interest.
Legislative Advocacy Meets Personal Profit
Since taking office in 2023, Crockett has co-sponsored federal marijuana decriminalization bills while her previous cannabis business attempts remained secret. This creates an obvious conflict where personal financial interests align suspiciously with legislative priorities. Her advocacy takes on a different character when viewed through the lens of potential personal enrichment rather than pure social justice.
The congresswoman’s defenders argue her business efforts were unsuccessful and therefore harmless. This misses the fundamental point about transparency and public trust. Voters deserve to know when their representatives have skin in the game, especially in industries undergoing rapid regulatory change. Crockett’s secrecy suggests she understood the political liability of her business pursuits.
Ethics Questions and Future Implications
This case highlights broader concerns about politicians entering regulated industries while maintaining legislative influence over those same sectors. Crockett’s situation demonstrates how the revolving door between business and politics can operate even before achieving high office. Her undisclosed interests represent exactly the kind of conflicts ethics rules are designed to prevent.
The revelation comes at a time when public trust in Congress remains near historic lows. Crockett’s failure to disclose significant financial interests reinforces cynical perceptions that politicians serve themselves first. Her case may prompt stricter enforcement of disclosure requirements and closer scrutiny of lawmakers’ business activities in emerging industries like cannabis.
Copyright 2025, DailyAnswer.org
